<html>
<head>PUBMED IDs for ADAMTS-3</head>
<body bgcolor='#C5F0F2'><h1>ADAMTS-3</h1><a href='https://pubmed.ncbi.nlm.nih.gov/22119775/'>Optimized refolding and characterization of active C-terminal ADAMTS-18 fragment from inclusion bodies of Escherichia coli.</a> June 8  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22119758/'>Evaluation of nilotinib in advanced GIST previously treated with imatinib and sunitinib.</a> July 28  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/24752352/'>IL-6 upregulates a disintegrin and metalloproteinase with thrombospondin motifs 2 (ADAMTS-2) in human osteosarcoma cells mediated by JNK pathway.</a> February 13  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24752338/'>SOX2 oncogenes amplified and operate to activate AKT signaling in gastric cancer and predict immunotherapy responsiveness.</a> August 5  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26232334/'>Induction of human ADAMTS-2 gene expression by IL-1Î± is mediated by a multiple crosstalk of MEK/JNK and PI3K pathways in osteoblast like cells.</a> December 19  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/28088271/'>ADAMTS-3, -13, -16, and -19 levels in patients with habitual abortion.</a> April 30  2017<br></body></html>
